Reacting to public criticism of the U.S. Food and Drug Administration’s (FDA’s) accelerated approval of Alzheimer’s disease treatment Aduhelm, the U.S. Department of Health and Human Services (HHS) recently announced […]
As the clinical trial industry works to more effectively promote diversity in the workplace, it’s important to remember that different perspectives are at the core of innovation—if conflicts are handled […]
Cancer clinical trials provide patients an opportunity to receive experimental drugs, tests, and/or procedures that can lead to remissions. For some, a clinical trial may seem like the only option; […]
The World Health Organization (WHO) has released new draft guidelines on good manufacturing practices (GMPs) for investigational therapeutics that impact clinical trial operations. Drugs used in clinical trials should […]
Women remain underrepresented in cardiovascular clinical trials despite guidelines and legal requirements developed almost 30 years ago to ensure broader inclusivity, according to recent reports in the Journal of the […]